Source: MassDevice

Precision Biopsy: Precision Biopsy asks FDA to OK new ClariCore trial

Precision Biopsy said today it submitted an application to the FDA seeking a go-ahead to expand the trial of its ClariCore prostate biopsy system into a new Transrectal Ultrasound and MR/Fusion arm. The ClariCore system is designed for the spectral analysis of tissue samples during biopsies to "rapidly classify" tissue as normal or suspicious using an [...]The post Precision Biopsy asks FDA to OK new ClariCore trial appeared first on MassDevice.

Read full article »

Top Competitors or Alternatives

Looks like nobody has added any competitors for Precision Biopsy yet.

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Amir Tehrani's photo - CEO of Precision Biopsy


Amir Tehrani

CEO Approval Rating


Precision Biopsy develops optical biopsy devices to improve the accuracy and reliability of prostate biopsies and the diagnosis of prostate cancer. Read more